OrbiMed Advisors LLC's Form 4 filing
TELA Bio, Inc. (TELA) · filed Apr 21, 2023
- Accession no.
- 0000947871-23-000484
- Filed
- Apr 21, 2023, 5:08 PM ET
- Trade date
- Apr 19-21, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions. Open-market sales total $1.79M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| OrbiMed Advisors LLCCIK 0001055951 | 10% Owner |
| OrbiMed Capital GP IV LLCCIK 0001502240 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 19, 2023 | Common Stock | SSaleDisposed | −136,000 | $9.30 | −$1,264,800 | 2,891,542 | Indirect | |
| Apr 20, 2023 | Common Stock | SSaleDisposed | −28,300 | $9.43 | −$266,869 | 2,863,242 | Indirect | |
| Apr 21, 2023 | Common Stock | SSaleDisposed | −27,700 | $9.41 | −$260,657 | 2,835,542 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.